CD8A and Splenomegaly: Confirming this predicted tolerogenic phenotype in our model, CD8α+ DC deficiency in B6.Batf3−/− mice significantly enhanced the severity of cGVHD, including splenomegaly and lymphocyte activation, thus confirming the predicted tolerogenic phenotype in our model.